
Plexus (PLXS) Stock Forecast & Price Target
Plexus (PLXS) Analyst Ratings
Bulls say
Plexus Corp is projecting significant growth in its Aerospace and Defense (A&D) segment, with expectations of exceeding prior growth targets of 9-12% for FY26, driven by robust demand in the Defense and Space subsectors. The Healthcare/Life Sciences sector, which constitutes a substantial 43.6% of its revenue, reported a strong quarterly increase, achieving $466 million and aligning with guidance for high-single to low-double-digit growth. Overall, Plexus's first-quarter revenue of $1.07 billion reflects a 9.6% year-over-year increase, further supported by an optimistic forecast of a 15.3% year-over-year rise in revenue for FQ2’26.
Bears say
Plexus Corp's financial outlook appears negative due to a significant decline in free cash flow, which fell to $7.4 million in the most recent quarter compared to $27 million in the year-ago period, highlighting potential liquidity concerns despite a target of approximately $100 million for the full fiscal year. The Industrial segment, which constituted 39.8% of the revenue in the first quarter, experienced a sequential decline of 7.6% and a year-over-year decline of 3.6%, indicating weakness in one of Plexus's major market verticals. Additionally, the company's return on invested capital (ROIC) decreased to 13.2% from the previous quarter, and performance metrics such as gross margin remained stagnant, suggesting challenges in operational efficiency and profitability amidst increasing economic uncertainties.
This aggregate rating is based on analysts' research of Plexus and is not a guaranteed prediction by Public.com or investment advice.
Plexus (PLXS) Analyst Forecast & Price Prediction
Start investing in Plexus (PLXS)
Order type
Buy in
Order amount
Est. shares
0 shares